2020-06-04

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and Fiscal Year End Dec 31, 2020. Stock Type Speculative Growth.

Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). Esperion Therapeutics' physical mailing address is 3891 RANCHERO DRIVE SUITE 150, ANN ARBOR MI, 48108. The biopharmaceutical company's listed phone number is 734-887-3903 and its investor relations email address is [email protected] The official website for Esperion Therapeutics is www.esperion.com. Company Name: Esperion Therapeutics, Stock Symbol: ESPR, Industry: Medical - Drugs, Total Posts: 261, Last Post: 12/15/2020 7:26:48 AM Wall Street Stock Market & Finance report, prediction for the future: You'll find the Esperion Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Esperion Therapeutics's ESPR shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

ESPR has a Sell rating from 2 analyst(s) out of 12 analysts who have looked at this stock. 4 analyst(s) recommend to Hold the stock while none of them suggest Overweight, and 6 recommend a Buy rating for it. You can buy and sell Esperion Therapeutics (ESPR) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages.

View 13F filing holders of Esperion Therapeutics Inc.. Funds Total 13F Shares Stock Price Volume Short Volume 13F Metrics Net Buys Average 13F Ranking

Company. Esperion Therapeutics, Inc. is a lipid management company. The Company is a late-stage pharmaceutical company focused on developing and commercializing once-daily, oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). Esperion Therapeutics' physical mailing address is 3891 RANCHERO DRIVE SUITE 150, ANN ARBOR MI, 48108.

Esperion Therapeutics Inc stock news This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash.

Find the latest Esperion Therapeutics, Inc. (ESPR) stock quote, history, news and other vital information to help you with your stock trading and investing. Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan 2021-04-08 · Esperion Therapeutics (NASDAQ: ESPR) shares are trading lower after Bank of America Securities downgraded the stock from Buy to Neutral and announced a price target of $35 per share.

This page ESPR stock forecast. Our latest prediction for Esperion Therapeutics Inc.'s stock price was made on the Nov. 3, 2020 when the stock price was at 24.20$. In the Technical Analysis for ESPR - Esperion Therapeutics, Inc. Quote; Chart; End-of- Day Signals; Intraday Alerts; Profile; Buy or Sell?
Reglera engelska

Esperion Therapeutics stock price target raised to $47 from $38 at J.P. Morgan Mar. 13, 2019 at 8:17 a.m. ET by Tomi Kilgore Esperion Therapeutics upgraded to neutral from underweight at J.P. Morgan Stock analysis for Esperion Therapeutics Inc (ESPR:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices.

2021-04-09 · Real time Esperion Therapeutics (ESPR) stock price quote, stock graph, news & analysis.
Data scientist interview questions

gratis cv mallar
victor grahn aktia
skriv talet i blandad form
subjuntivo perfecto vs imperfecto
områdeschef samhall lön 2021

Esperion Therapeutics Inc Stock Forecast. Over the next 52 weeks, Esperion Therapeutics Inc has on average historically risen by 103.3 % based on the past 7 years of stock performance. Esperion Therapeutics Inc has risen higher in 3 of those 7 years over the subsequent 52 week period, corresponding to a historical accuracy of 50 %

2 months ago - Benzinga. ESPERION | Stock Information. ESPR: Get the latest Esperion Therapeutics stock price and detailed information including ESPR news, historical charts and realtime prices. 2021-02-23 · Esperion Therapeutics' stock was trading at $42.93 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ESPR stock has decreased by 39.6% and is now trading at $25.93.